FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
US$24.25 Million Accessed to Develop the La Arena… (RIO, May 2010) | FRC
Home🔹Latest Reports🔹Rio Tinto Group🔹US$24.25 Million Accessed to Develop the La Arena Gold Oxide Project
Rio Tinto Group

US$24.25 Million Accessed to Develop the La Arena Gold Oxide Project

ByFRC TeamMay 20, 2010

Disclosure: Rio Tinto Group has paid FRC a fee for research coverage and distribution of reports. See last page for other important disclosures, rating, and risk definitions.

Rating and Key Data

Locked
MetricsValue
Free with an FRC account

Unlock the full RIO analysis — free account

The rating, fair value and the complete Rio Tinto Group profile — not just a price:
ValuationFair value, FRC rating & peer comparablesFundamentalsFinancials, ratios, earnings & dividendsWho's buyingInstitutions, insiders & Congress tradesContextLive quote, chart, news & FRC reports
No credit card. Already have an account?
Preview the RIO profile

Rating and Key Data

Locked
MetricsValue
Free with an FRC account

Unlock the full RIO analysis — free account

The rating, fair value and the complete Rio Tinto Group profile — not just a price:
ValuationFair value, FRC rating & peer comparablesFundamentalsFinancials, ratios, earnings & dividendsWho's buyingInstitutions, insiders & Congress tradesContextLive quote, chart, news & FRC reports
No credit card. Already have an account?
Preview the RIO profile

Related Content

More Research Reports

Market Intel Weekly

Promising Drill Results, Sleep Gummy Launch, and Biotech Advancements

March 17, 2025
Thumbnail for Promising Drill Results, Sleep Gummy Launch, and Biotech Advancements
Market Intel Weekly

Finding Stability Amid Trump’s Trade War

March 10, 2025
Thumbnail for Finding Stability Amid Trump’s Trade War
Market Intel Weekly

Top Picks Soar, Key Resource Updates, and CEO Investment in Lender

March 10, 2025
Thumbnail for Top Picks Soar, Key Resource Updates, and CEO Investment in Lender
Market Intel Weekly

Ranking Central Bank Dovishness: Rate Cut Projections and Policy Analysis

March 3, 2025
Thumbnail for Ranking Central Bank Dovishness: Rate Cut Projections and Policy Analysis
Gensource Potash Corporation

Redefining Potash Mining: A Game-Changing Partnership in the Making

July 12, 2026
Redefining Potash Mining: A Game-Changing Partnership in the Making
BluSky AI, Inc.

Building Infrastructure Capacity for the AI Era – Initiating Coverage

July 10, 2026
Building Infrastructure Capacity for the AI Era – Initiating Coverage
Monument Mining Limited

Executing on All Fronts, While Remaining Deeply Undervalued

June 24, 2026
Executing on All Fronts, While Remaining Deeply Undervalued
Silver X Mining Corp.

Earnings Inflection and Expanding Resource Pipeline

June 20, 2026
Earnings Inflection and Expanding Resource Pipeline

From the FRC Archive

  • New 25+ Moz Gold Discovery in the Golden Triangle – Initiating CoverageTudor Gold Corp. · 2021
  • Growing 2x Faster Than the Market – FINAL REPORTInner Spirit Holdings · 2021
  • Extracts Company Positioned for Cannabis 2.0 and Mushrooms – Initiating CoveragePure Extracts Technologies Corp. · 2021
  • Targeting Same Mental Health Space Where GW Pharma was Acquired for U$7.2B Last Month – Initiating CoverageCanaQuest Medical Corp. · 2021